Literature DB >> 19571316

Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation.

Anna Rita Migliaccio1, Fabrizio Martelli, Maria Verrucci, Massimo Sanchez, Mauro Valeri, Giovanni Migliaccio, Alessandro Maria Vannucchi, Maria Zingariello, Angela Di Baldassarre, Barbara Ghinassi, Rosa Alba Rana, Yvette van Hensbergen, Willem E Fibbe.   

Abstract

Rigorously defined reconstitution assays developed in recent years have allowed recognition of the delicate relationship that exists between hematopoietic stem cells and their niches. This balance ensures that hematopoiesis occurs in the marrow under steady-state conditions. However, during development, recovery from hematopoietic stress and in myeloproliferative disorders, hematopoiesis occurs in extramedullary sites whose microenvironments are still poorly defined. The hypomorphic Gata1(low) mutation deletes the regulatory sequences of the gene necessary for its expression in hematopoietic cells generated in the marrow. By analyzing the mechanism that rescues hematopoiesis in mice carrying this mutation, we provide evidence that extramedullary microenvironments sustain maturation of stem cells that would be otherwise incapable of maturing in the marrow.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571316      PMCID: PMC2744572          DOI: 10.1182/blood-2009-03-211680

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.

Authors:  K Akashi; D Traver; T Miyamoto; I L Weissman
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

2.  Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice).

Authors:  Alessandro Maria Vannucchi; Lucia Bianchi; Cristina Cellai; Francesco Paoletti; Rosa Alba Rana; Rodolfo Lorenzini; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 3.  Stem cells and their niches.

Authors:  Kateri A Moore; Ihor R Lemischka
Journal:  Science       Date:  2006-03-31       Impact factor: 47.728

4.  Clonogenic mast cell progenitors and their excess numbers in chimeric BALB/c mice with inactivated GATA-1.

Authors:  Donald Metcalf; Ian Majewski; Sandra Mifsud; Ladina Di Rago; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

Review 5.  Stem-cell ecology and stem cells in motion.

Authors:  Thalia Papayannopoulou; David T Scadden
Journal:  Blood       Date:  2008-04-15       Impact factor: 22.113

6.  Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.

Authors:  Yojiro Arinobu; Shin-ichi Mizuno; Yong Chong; Hirokazu Shigematsu; Tadafumi Iino; Hiromi Iwasaki; Thomas Graf; Robin Mayfield; Susan Chan; Philippe Kastner; Koichi Akashi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

7.  Identification of distinctive stromal elements in erythroid and neutrophil granuloid spleen colonies: light and electron microscopic study.

Authors:  R W La Pushin; J J Trentin
Journal:  Exp Hematol       Date:  1977-11       Impact factor: 3.084

8.  Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds.

Authors:  Fabrizio Martelli; Barbara Ghinassi; Barbara Panetta; Elena Alfani; Valentina Gatta; Alessandro Pancrazzi; Costanza Bogani; Alessandro Maria Vannucchi; Francesco Paoletti; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

9.  Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Alessandro Maria Vannucchi; Hongyu Ni; Mingjiang Xu; Yi Jiang; Betty Nakamoto; Thalia Papayannopoulou; Ronald Hoffman
Journal:  Exp Hematol       Date:  2008-02       Impact factor: 3.084

10.  The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells.

Authors:  William B Slayton; Ann Georgelas; L Jeanne Pierce; Kojo S Elenitoba-Johnson; S Scott Perry; Melissa Marx; Gerald J Spangrude
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

View more
  19 in total

1.  CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin.

Authors:  Maria Verrucci; Alessandro Pancrazzi; Miguel Aracil; Fabrizio Martelli; Paola Guglielmelli; Maria Zingariello; Barbara Ghinassi; Emanuela D'Amore; José Jimeno; Alessandro M Vannucchi; Anna Rita Migliaccio
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 2.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

3.  Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.

Authors:  Eva Zetterberg; Maria Verrucci; Fabrizio Martelli; Maria Zingariello; Laura Sancillo; Emanuela D'Amore; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Platelets       Date:  2013-10-31       Impact factor: 3.862

4.  The Human GATA1 Gene Retains a 5' Insulator That Maintains Chromosomal Architecture and GATA1 Expression Levels in Splenic Erythroblasts.

Authors:  Takashi Moriguchi; Lei Yu; Jun Takai; Makiko Hayashi; Hironori Satoh; Mikiko Suzuki; Kinuko Ohneda; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

5.  Evidence for organ-specific stem cell microenvironments.

Authors:  Barbara Ghinassi; Fabrizio Martelli; Maria Verrucci; Emanuela D'Amore; Giovanni Migliaccio; Alessandro Maria Vannucchi; Ronald Hoffman; Anna Rita Migliaccio
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

6.  Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

Authors:  Ilaria Ceglia; Amylou C Dueck; Francesca Masiello; Fabrizio Martelli; Wu He; Giulia Federici; Emanuel F Petricoin; Ann Zeuner; Camelia Iancu-Rubin; Rona Weinberg; Ronald Hoffman; John Mascarenhas; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2016-08-31       Impact factor: 3.084

7.  A novel interaction between megakaryocytes and activated fibrocytes increases TGF-β bioavailability in the Gata1(low) mouse model of myelofibrosis.

Authors:  Maria Zingariello; Alessandra Ruggeri; Fabrizio Martelli; Manuela Marra; Laura Sancillo; Ilaria Ceglia; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Am J Blood Res       Date:  2015-12-25

Review 8.  Novel targets to cure primary myelofibrosis from studies on Gata1low mice.

Authors:  Maria Zingariello; Fabrizio Martelli; Paola Verachi; Claudio Bardelli; Francesca Gobbo; Maria Mazzarini; Anna Rita Migliaccio
Journal:  IUBMB Life       Date:  2019-11-21       Impact factor: 3.885

9.  Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis.

Authors:  Maria Zingariello; Fabrizio Martelli; Fiorella Ciaffoni; Francesca Masiello; Barbara Ghinassi; Emanuela D'Amore; Margherita Massa; Giovanni Barosi; Laura Sancillo; Xiaochun Li; Judith D Goldberg; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Blood       Date:  2013-03-05       Impact factor: 22.113

10.  Reappraising the role of α5 integrin and the microenvironmental support in stress erythropoiesis.

Authors:  Tatyana Ulyanova; Grigorios Georgolopoulos; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2019-12-28       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.